Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$98.94M
14 trades · 4 insiders
Net · 90d
$-98.94M
Insiders on file
54
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Woods Eugene A. | Director | 16 | $0 | $0 | 2026-09-08 |
| Pinto Daniel E | Director | 7 | $0 | $0 | 2026-09-08 |
| HEWSON MARILLYN A | Director | 37 | $419.0K | $0 | 2026-09-08 |
| Schmid Timothy | EVP, WW Chair, MedTech | 64 | $0 | $24.38M | 2026-09-02 |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | 105 | $0 | $40.82M | 2026-08-17 |
| Duato Joaquin | Vice Chair, Exec Committee | 150 | $0 | $146.06M | 2026-08-13 |
| Forminard Elizabeth | Executive VP, General Counsel | 63 | $0 | $8.18M | 2026-08-06 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | 67 | $0 | $8.74M | 2026-07-20 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | 115 | $0 | $16.93M | 2026-06-11 |
| REED JOHN C | EVP, Pharmaceuticals R&D | 39 | $0 | $20.42M | 2026-05-01 |
| West Nadja | Director | 6 | $0 | $0 | 2026-04-23 |
| WEINBERGER MARK A | Director | 20 | $147.2K | $0 | 2026-04-23 |
| Doudna Jennifer A | Director | 8 | $0 | $0 | 2026-04-23 |
| McClellan Mark B. | Director | 13 | $0 | $0 | 2026-04-23 |
| Beckerle Mary C | Director | 11 | $0 | $0 | 2026-04-23 |
| Joly Hubert | Director | 8 | $706.4K | $0 | 2026-04-23 |
| Johnson Paula A | Director | 4 | $0 | $0 | 2026-04-23 |
| MORIKIS JOHN G | Director | 2 | $257.7K | $0 | 2026-04-23 |
| Decker Robert J | VP Corporate Controller | 98 | $0 | $9.28M | 2026-02-27 |
| Swanson James D. | See Remarks | 64 | $0 | $15.27M | 2026-02-17 |
| Wolk Joseph J | Exec VP, CFO | 113 | $0 | $29.40M | 2026-02-17 |
| Mulholland Kristen | EVP, Chief HR Officer | 33 | $0 | $0 | 2026-02-15 |
| Adamczyk Darius | Director | 3 | $0 | $0 | 2024-04-25 |
| DAVIS D SCOTT | Director | 10 | $0 | $0 | 2024-04-25 |
| MULCAHY ANNE M | Director | 17 | $100.1K | $0 | 2024-04-25 |
| Hait William | See Remarks | 45 | $0 | $10.55M | 2024-02-15 |
| Fasolo Peter | VP, Worldwide Human Resources | 415 | $0 | $80.99M | 2024-02-15 |
| McEvoy Ashley | EVP, WW Chair, Medical Devices | 52 | $0 | $17.14M | 2023-08-23 |
| Washington A. Eugene | Director | 61 | $0 | $0 | 2023-03-07 |
| Mongon Thibaut | Exec VP, WW Chair, Consumer | 87 | $0 | $17.93M | 2023-02-13 |
| Gorsky Alex | Member, Executive Committee | 112 | $0 | $38.60M | 2023-01-17 |
| Ullmann Michael H | VP, General Counsel | 117 | $0 | $7.64M | 2022-02-15 |
| Davis Ian | Director | 14 | $0 | $0 | 2022-02-15 |
| Mammen Mathai | EVP, Pharm, R&D | 8 | $0 | $0 | 2022-02-15 |
| PRINCE CHARLES | Director | 18 | $864.8K | $0 | 2022-02-15 |
| WILLIAMS RONALD A | Director | 46 | $0 | $0 | 2022-02-15 |
| Sneed Michael E | EVP, Global Corp Aff & COO | 39 | $0 | $25.36M | 2021-02-12 |
| Stoffels Paulus | Vice Chair, Exec Committee | 104 | $0 | $72.29M | 2021-02-12 |
| PEREZ WILLIAM D | Director | 39 | $197.8K | $0 | 2020-03-13 |
| Kapusta Ronald A | Controller, CAO | 54 | $0 | $6.41M | 2019-02-11 |
| Mesquita Jorge S. | Exec VP, WW Chair, Consumer | 14 | $0 | $0 | 2019-02-11 |
| Caruso Dominic J | VP, Finance; CFO | 85 | $0 | $25.84M | 2018-02-12 |
| PETERSON SANDRA E | Group Worldwide Chairman | 48 | $0 | $0 | 2018-02-12 |
| Pruden Gary J | Exec VP, WW Chair, Med Devices | 9 | $0 | $3.12M | 2017-02-28 |
| LINDQUIST SUSAN L | Director | 38 | $0 | $532.2K | 2016-09-06 |
| COLEMAN MARY SUE | Director | 16 | $0 | $526.4K | 2016-02-08 |
| MULLIN LEO F | Director | 15 | $0 | $0 | 2015-02-09 |
| COSGROVE STEPHEN J | Corporate Controller | 51 | $0 | $5.40M | 2015-02-09 |
| CULLEN JAMES | Director | 16 | $0 | $1.64M | 2015-02-09 |
| JOHNS MICHAEL M E | Director | 17 | $0 | $0 | 2014-02-10 |
| SATCHER DAVID | Director | 7 | $0 | $0 | 2013-02-11 |
| WELDON WILLIAM C | Other | 18 | $0 | $51.43M | 2013-02-08 |
| DEYO RUSSELL C | VP, General Counsel | 14 | $0 | $1.02M | 2012-02-22 |
| McCoy Sherilyn S | Member, Executive Committee | 8 | $0 | $0 | 2012-02-09 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| HEWSON MARILLYN A | Director | A Award deriv | 2026-09-08 | 2026-09-10 | 181 | $276.31 | $50.0K | 16,049 | SEC↗ |
| Woods Eugene A. | Director | A Award deriv | 2026-09-08 | 2026-09-10 | 136 | $276.31 | $37.5K | 6,579 | SEC↗ |
| Pinto Daniel E | Director | A Award deriv | 2026-09-08 | 2026-09-10 | 113 | $276.31 | $31.3K | 2,445 | SEC↗ |
| Pinto Daniel E | Director | A Award deriv | 2026-09-08 | 2026-09-10 | 113 | $276.31 | $31.3K | 2,445 | SEC↗ |
| Woods Eugene A. | Director | A Award deriv | 2026-09-08 | 2026-09-10 | 136 | $276.31 | $37.5K | 6,579 | SEC↗ |
| HEWSON MARILLYN A | Director | A Award deriv | 2026-09-08 | 2026-09-10 | 181 | $276.31 | $50.0K | 16,049 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise deriv | 2026-09-02 | 2026-09-04 | 22,527 | — | $0 | 0 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise deriv | 2026-09-02 | 2026-09-04 | 11,070 | — | $0 | 0 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 2026-09-02 | 2026-09-04 | 22,527 | $151.41 | $3.41M | 47,974 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 2026-09-02 | 2026-09-04 | 11,070 | $131.94 | $1.46M | 36,517 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | S Sale | 2026-09-02 | 2026-09-04 | 11,070 | $274.74 | $3.04M | 25,447 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | S Sale | 2026-09-02 | 2026-09-04 | 22,527 | $274.74 | $6.19M | 25,447 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise deriv | 2026-09-02 | 2026-09-04 | 22,527 | — | $0 | 0 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise deriv | 2026-09-02 | 2026-09-04 | 11,070 | — | $0 | 0 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | S Sale | 2026-09-02 | 2026-09-04 | 22,527 | $274.74 | $6.19M | 25,447 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 2026-09-02 | 2026-09-04 | 22,527 | $151.41 | $3.41M | 47,974 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | S Sale | 2026-09-02 | 2026-09-04 | 11,070 | $274.74 | $3.04M | 25,447 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 2026-09-02 | 2026-09-04 | 11,070 | $131.94 | $1.46M | 36,517 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise deriv | 2026-08-17 | 2026-08-18 | 15,000 | — | $0 | 28,712 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise | 2026-08-17 | 2026-08-18 | 15,000 | $115.67 | $1.74M | 209,451 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | S Sale | 2026-08-17 | 2026-08-18 | 15,000 | $263.36 | $3.95M | 194,451 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise deriv | 2026-08-17 | 2026-08-18 | 15,000 | — | $0 | 28,712 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | S Sale | 2026-08-17 | 2026-08-18 | 15,000 | $263.36 | $3.95M | 194,451 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise | 2026-08-17 | 2026-08-18 | 15,000 | $115.67 | $1.74M | 209,451 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise deriv | 2026-08-13 | 2026-08-14 | 123,291 | — | $0 | 0 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | S Sale | 2026-08-13 | 2026-08-14 | 102,315 | $261.00 | $26.70M | 275,967 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise | 2026-08-13 | 2026-08-14 | 123,291 | $115.67 | $14.26M | 399,258 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | S Sale | 2026-08-13 | 2026-08-14 | 20,976 | $262.00 | $5.50M | 378,282 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise deriv | 2026-08-13 | 2026-08-14 | 123,291 | — | $0 | 0 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | S Sale | 2026-08-13 | 2026-08-14 | 102,315 | $261.00 | $26.70M | 275,967 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | S Sale | 2026-08-13 | 2026-08-14 | 20,976 | $262.00 | $5.50M | 378,282 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise | 2026-08-13 | 2026-08-14 | 123,291 | $115.67 | $14.26M | 399,258 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise deriv | 2026-08-06 | 2026-08-07 | 9,344 | — | $0 | 0 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | S Sale | 2026-08-06 | 2026-08-07 | 9,344 | $257.76 | $2.41M | 23,568 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise | 2026-08-06 | 2026-08-07 | 9,344 | $131.94 | $1.23M | 32,912 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | S Sale | 2026-08-06 | 2026-08-07 | 6,574 | $255.93 | $1.68M | 16,994 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise deriv | 2026-08-06 | 2026-08-07 | 9,344 | — | $0 | 0 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | S Sale | 2026-08-06 | 2026-08-07 | 6,574 | $255.93 | $1.68M | 16,994 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | S Sale | 2026-08-06 | 2026-08-07 | 9,344 | $257.75 | $2.41M | 23,568 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise | 2026-08-06 | 2026-08-07 | 9,344 | $131.94 | $1.23M | 32,912 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | S Sale | 2026-08-05 | 2026-08-07 | 6,523 | $258.74 | $1.69M | 275,967 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | S Sale | 2026-08-05 | 2026-08-07 | 41,957 | $258.06 | $10.83M | 282,490 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | S Sale | 2026-08-05 | 2026-08-07 | 6,523 | $258.74 | $1.69M | 275,967 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | S Sale | 2026-08-05 | 2026-08-07 | 41,957 | $258.06 | $10.83M | 282,490 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise deriv | 2026-07-20 | 2026-07-21 | 11,925 | — | $0 | 0 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise deriv | 2026-07-20 | 2026-07-21 | 11,129 | — | $0 | 0 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | S Sale | 2026-07-20 | 2026-07-21 | 23,054 | $251.27 | $5.79M | 23,003 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise | 2026-07-20 | 2026-07-21 | 11,925 | $131.94 | $1.57M | 46,057 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise | 2026-07-20 | 2026-07-21 | 11,129 | $129.51 | $1.44M | 34,132 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | M Exercise deriv | 2026-06-11 | 2026-06-12 | 10,000 | — | $0 | 32,965 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | M Exercise | 2026-06-11 | 2026-06-12 | 10,000 | $115.67 | $1.16M | 124,288 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | S Sale | 2026-06-11 | 2026-06-12 | 10,000 | $241.15 | $2.41M | 114,288 | SEC↗ |
| HEWSON MARILLYN A | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 215 | $232.79 | $50.0K | 15,792 | SEC↗ |
| Pinto Daniel E | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 134 | $232.79 | $31.2K | 2,321 | SEC↗ |
| Woods Eugene A. | Director | A Award deriv | 2026-06-09 | 2026-06-11 | 161 | $232.79 | $37.5K | 6,412 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | M Exercise deriv | 2026-05-01 | 2026-05-04 | 25,255 | — | $0 | 0 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | M Exercise | 2026-05-01 | 2026-05-04 | 25,255 | — | $0 | 35,913 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | F Tax w/h | 2026-05-01 | 2026-05-04 | 11,002 | $229.85 | $2.53M | 24,911 | SEC↗ |
| Beckerle Mary C | Director | A Award deriv | 2026-04-23 | 2026-04-27 | 975 | — | $0 | 16,798 | SEC↗ |
| Doudna Jennifer A | Director | A Award deriv | 2026-04-23 | 2026-04-27 | 975 | — | $0 | 10,899 | SEC↗ |
| HEWSON MARILLYN A | Director | A Award deriv | 2026-04-23 | 2026-04-27 | 975 | — | $0 | 15,488 | SEC↗ |
| Johnson Paula A | Director | A Award deriv | 2026-04-23 | 2026-04-27 | 975 | — | $0 | 5,359 | SEC↗ |
| Joly Hubert | Director | A Award deriv | 2026-04-23 | 2026-04-27 | 975 | — | $0 | 9,184 | SEC↗ |
| McClellan Mark B. | Director | A Award deriv | 2026-04-23 | 2026-04-27 | 975 | — | $0 | 21,279 | SEC↗ |
| MORIKIS JOHN G | Director | A Award deriv | 2026-04-23 | 2026-04-27 | 1,540 | — | $0 | 1,540 | SEC↗ |
| Pinto Daniel E | Director | A Award deriv | 2026-04-23 | 2026-04-27 | 1,712 | — | $0 | 2,174 | SEC↗ |
| WEINBERGER MARK A | Director | A Award deriv | 2026-04-23 | 2026-04-27 | 975 | — | $0 | 12,010 | SEC↗ |
| West Nadja | Director | A Award deriv | 2026-04-23 | 2026-04-27 | 975 | — | $0 | 7,730 | SEC↗ |
| Woods Eugene A. | Director | A Award deriv | 2026-04-23 | 2026-04-27 | 975 | — | $0 | 6,215 | SEC↗ |
| Woods Eugene A. | Director | A Award deriv | 2026-03-10 | 2026-03-12 | 155 | $242.14 | $37.5K | 5,240 | SEC↗ |
| Pinto Daniel E | Director | A Award deriv | 2026-03-10 | 2026-03-12 | 129 | $242.14 | $31.3K | 462 | SEC↗ |
| HEWSON MARILLYN A | Director | A Award deriv | 2026-03-10 | 2026-03-12 | 206 | $242.14 | $50.0K | 14,513 | SEC↗ |
| Decker Robert J | VP Corporate Controller | M Exercise deriv | 2026-02-27 | 2026-03-03 | 4,075 | — | $0 | 0 | SEC↗ |
| Decker Robert J | VP Corporate Controller | M Exercise | 2026-02-27 | 2026-03-03 | 4,075 | $115.67 | $471.4K | 27,757 | SEC↗ |
| Decker Robert J | VP Corporate Controller | S Sale | 2026-02-27 | 2026-03-03 | 4,075 | $247.87 | $1.01M | 23,682 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | S Sale | 2026-02-20 | 2026-02-23 | 1,322 | $245.66 | $324.8K | 25,447 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise deriv | 2026-02-18 | 2026-02-18 | 8,998 | — | $0 | 0 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise deriv | 2026-02-18 | 2026-02-18 | 13,625 | — | $0 | 0 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 2026-02-18 | 2026-02-18 | 13,625 | $115.67 | $1.58M | 40,394 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | S Sale | 2026-02-18 | 2026-02-18 | 13,625 | $244.20 | $3.33M | 26,769 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 2026-02-18 | 2026-02-18 | 8,998 | $129.51 | $1.17M | 35,767 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | S Sale | 2026-02-18 | 2026-02-18 | 8,998 | $244.53 | $2.20M | 26,769 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | M Exercise deriv | 2026-02-17 | 2026-02-18 | 29,927 | — | $0 | 59,854 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | M Exercise deriv | 2026-02-17 | 2026-02-18 | 21,721 | — | $0 | 21,721 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise deriv | 2026-02-17 | 2026-02-18 | 19,241 | — | $0 | 0 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise deriv | 2026-02-17 | 2026-02-18 | 12,066 | — | $0 | 0 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise deriv | 2026-02-17 | 2026-02-18 | 33,386 | — | $0 | 33,000 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise deriv | 2026-02-17 | 2026-02-18 | 20,521 | — | $0 | 0 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | S Sale | 2026-02-17 | 2026-02-18 | 6,197 | $243.39 | $1.51M | 23,003 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | M Exercise | 2026-02-17 | 2026-02-18 | 21,721 | $157.92 | $3.43M | 34,662 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | S Sale | 2026-02-17 | 2026-02-18 | 21,721 | $243.00 | $5.28M | 12,941 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | S Sale | 2026-02-17 | 2026-02-18 | 2,283 | $243.00 | $554.8K | 10,658 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | S Sale | 2026-02-17 | 2026-02-18 | 29,927 | $243.00 | $7.27M | 12,941 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | M Exercise | 2026-02-17 | 2026-02-18 | 29,927 | $156.15 | $4.67M | 42,868 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | S Sale | 2026-02-17 | 2026-02-18 | 12,066 | $242.87 | $2.93M | 38,961 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise | 2026-02-17 | 2026-02-18 | 33,386 | $131.94 | $4.40M | 72,347 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | S Sale | 2026-02-17 | 2026-02-18 | 33,386 | $242.75 | $8.10M | 38,961 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | S Sale | 2026-02-17 | 2026-02-18 | 24,961 | $242.68 | $6.06M | 14,000 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | S Sale | 2026-02-17 | 2026-02-18 | 19,241 | $242.99 | $4.68M | 38,961 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise | 2026-02-17 | 2026-02-18 | 19,241 | $115.67 | $2.23M | 58,202 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise | 2026-02-17 | 2026-02-18 | 12,066 | $129.51 | $1.56M | 51,027 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise | 2026-02-17 | 2026-02-18 | 20,521 | $164.62 | $3.38M | 46,219 | SEC↗ |
| Swanson James D. | EVP, CIO | S Sale | 2026-02-17 | 2026-02-18 | 20,521 | $242.70 | $4.98M | 25,698 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | A Award deriv | 2026-02-15 | 2026-02-18 | 14,405 | — | $0 | 14,405 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise deriv | 2026-02-15 | 2026-02-18 | 492 | — | $0 | 491 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise deriv | 2026-02-15 | 2026-02-18 | 526 | — | $0 | 1,050 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | A Award deriv | 2026-02-15 | 2026-02-18 | 1,034 | — | $0 | 1,034 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise deriv | 2026-02-15 | 2026-02-18 | 4,505 | — | $0 | 9,008 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise deriv | 2026-02-15 | 2026-02-18 | 3,682 | — | $0 | 3,682 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | A Award deriv | 2026-02-15 | 2026-02-18 | 9,459 | — | $0 | 9,459 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | A Award deriv | 2026-02-15 | 2026-02-18 | 131,734 | — | $0 | 131,734 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | A Award deriv | 2026-02-15 | 2026-02-18 | 2,548 | — | $0 | 2,548 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | A Award deriv | 2026-02-15 | 2026-02-18 | 35,489 | — | $0 | 35,489 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise deriv | 2026-02-15 | 2026-02-18 | 1,026 | — | $0 | 2,051 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise deriv | 2026-02-15 | 2026-02-18 | 1,028 | — | $0 | 1,028 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | A Award deriv | 2026-02-15 | 2026-02-18 | 54,869 | — | $0 | 54,869 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | A Award deriv | 2026-02-15 | 2026-02-18 | 3,940 | — | $0 | 3,940 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise deriv | 2026-02-15 | 2026-02-18 | 1,847 | — | $0 | 3,692 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise deriv | 2026-02-15 | 2026-02-18 | 1,594 | — | $0 | 1,594 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | A Award deriv | 2026-02-15 | 2026-02-18 | 1,944 | — | $0 | 1,944 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | A Award deriv | 2026-02-15 | 2026-02-18 | 27,076 | — | $0 | 27,076 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise deriv | 2026-02-15 | 2026-02-18 | 1,063 | — | $0 | 2,126 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise deriv | 2026-02-15 | 2026-02-18 | 961 | — | $0 | 961 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | M Exercise deriv | 2026-02-15 | 2026-02-18 | 1,349 | — | $0 | 1,349 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | M Exercise deriv | 2026-02-15 | 2026-02-18 | 1,847 | — | $0 | 3,692 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | A Award deriv | 2026-02-15 | 2026-02-18 | 49,382 | — | $0 | 49,382 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | A Award deriv | 2026-02-15 | 2026-02-18 | 3,546 | — | $0 | 3,546 | SEC↗ |
| Decker Robert J | VP Corporate Controller | A Award deriv | 2026-02-15 | 2026-02-18 | 700 | — | $0 | 700 | SEC↗ |
| Decker Robert J | VP Corporate Controller | M Exercise deriv | 2026-02-15 | 2026-02-18 | 339 | — | $0 | 338 | SEC↗ |
| Decker Robert J | VP Corporate Controller | M Exercise deriv | 2026-02-15 | 2026-02-18 | 344 | — | $0 | 687 | SEC↗ |
| Decker Robert J | VP Corporate Controller | A Award deriv | 2026-02-15 | 2026-02-18 | 4,871 | — | $0 | 4,871 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise deriv | 2026-02-15 | 2026-02-18 | 1,971 | — | $0 | 1,971 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise deriv | 2026-02-15 | 2026-02-18 | 1,878 | — | $0 | 3,754 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | A Award deriv | 2026-02-15 | 2026-02-18 | 53,793 | — | $0 | 53,793 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | A Award deriv | 2026-02-15 | 2026-02-18 | 3,863 | — | $0 | 3,863 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | M Exercise deriv | 2026-02-15 | 2026-02-18 | 419 | — | $0 | 418 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | M Exercise deriv | 2026-02-15 | 2026-02-18 | 575 | — | $0 | 1,150 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | A Award deriv | 2026-02-15 | 2026-02-18 | 20,322 | — | $0 | 20,322 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | A Award deriv | 2026-02-15 | 2026-02-18 | 1,459 | — | $0 | 1,459 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | M Exercise deriv | 2026-02-15 | 2026-02-18 | 606 | — | $0 | 606 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | M Exercise deriv | 2026-02-15 | 2026-02-18 | 635 | — | $0 | 1,268 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | A Award deriv | 2026-02-15 | 2026-02-18 | 16,945 | — | $0 | 16,945 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | A Award deriv | 2026-02-15 | 2026-02-18 | 1,217 | — | $0 | 1,217 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise deriv | 2026-02-15 | 2026-02-18 | 709 | — | $0 | 1,418 | SEC↗ |
| Swanson James D. | EVP, CIO | A Award deriv | 2026-02-15 | 2026-02-18 | 1,397 | — | $0 | 1,397 | SEC↗ |
| Swanson James D. | EVP, CIO | A Award deriv | 2026-02-15 | 2026-02-18 | 19,449 | — | $0 | 19,449 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise deriv | 2026-02-15 | 2026-02-18 | 492 | — | $0 | 491 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | F Tax w/h | 2026-02-15 | 2026-02-18 | 252 | $243.45 | $61.3K | 28,944 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise | 2026-02-15 | 2026-02-18 | 526 | — | $0 | 29,470 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise | 2026-02-15 | 2026-02-18 | 492 | — | $0 | 29,196 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | F Tax w/h | 2026-02-15 | 2026-02-18 | 270 | $243.45 | $65.7K | 29,200 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise | 2026-02-15 | 2026-02-18 | 4,505 | — | $0 | 326,407 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | F Tax w/h | 2026-02-15 | 2026-02-18 | 1,602 | $243.45 | $390.0K | 321,902 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise | 2026-02-15 | 2026-02-18 | 3,682 | — | $0 | 323,504 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | F Tax w/h | 2026-02-15 | 2026-02-18 | 1,960 | $243.45 | $477.2K | 324,447 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 2026-02-15 | 2026-02-18 | 1,028 | — | $0 | 26,206 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | F Tax w/h | 2026-02-15 | 2026-02-18 | 15 | $243.45 | $3.7K | 26,191 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 2026-02-15 | 2026-02-18 | 1,026 | — | $0 | 27,217 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | F Tax w/h | 2026-02-15 | 2026-02-18 | 448 | $243.45 | $109.1K | 26,769 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | F Tax w/h | 2026-02-15 | 2026-02-18 | 945 | $243.45 | $230.1K | 194,451 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise | 2026-02-15 | 2026-02-18 | 1,847 | — | $0 | 195,396 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | F Tax w/h | 2026-02-15 | 2026-02-18 | 816 | $243.45 | $198.7K | 193,549 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise | 2026-02-15 | 2026-02-18 | 1,594 | — | $0 | 194,365 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise | 2026-02-15 | 2026-02-18 | 961 | — | $0 | 23,541 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | F Tax w/h | 2026-02-15 | 2026-02-18 | 492 | $243.45 | $119.8K | 23,049 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise | 2026-02-15 | 2026-02-18 | 1,063 | — | $0 | 24,112 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | F Tax w/h | 2026-02-15 | 2026-02-18 | 544 | $243.45 | $132.4K | 23,568 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | F Tax w/h | 2026-02-15 | 2026-02-18 | 385 | $243.45 | $93.7K | 11,622 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | F Tax w/h | 2026-02-15 | 2026-02-18 | 528 | $243.45 | $128.5K | 12,941 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | M Exercise | 2026-02-15 | 2026-02-18 | 1,847 | — | $0 | 13,469 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | M Exercise | 2026-02-15 | 2026-02-18 | 1,349 | — | $0 | 12,007 | SEC↗ |
| Decker Robert J | VP Corporate Controller | F Tax w/h | 2026-02-15 | 2026-02-18 | 95 | $243.45 | $23.1K | 23,682 | SEC↗ |
| Decker Robert J | VP Corporate Controller | M Exercise | 2026-02-15 | 2026-02-18 | 344 | — | $0 | 23,777 | SEC↗ |
| Decker Robert J | VP Corporate Controller | F Tax w/h | 2026-02-15 | 2026-02-18 | 94 | $243.45 | $22.9K | 23,433 | SEC↗ |
| Decker Robert J | VP Corporate Controller | M Exercise | 2026-02-15 | 2026-02-18 | 339 | — | $0 | 23,527 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | F Tax w/h | 2026-02-15 | 2026-02-18 | 858 | $243.45 | $208.9K | 37,900 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | F Tax w/h | 2026-02-15 | 2026-02-18 | 817 | $243.45 | $198.9K | 38,961 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise | 2026-02-15 | 2026-02-18 | 1,971 | — | $0 | 38,758 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise | 2026-02-15 | 2026-02-18 | 1,878 | — | $0 | 39,778 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | M Exercise | 2026-02-15 | 2026-02-18 | 419 | — | $0 | 19,678 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | F Tax w/h | 2026-02-15 | 2026-02-18 | 172 | $243.45 | $41.9K | 19,506 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | F Tax w/h | 2026-02-15 | 2026-02-18 | 251 | $243.45 | $61.1K | 19,830 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | M Exercise | 2026-02-15 | 2026-02-18 | 575 | — | $0 | 20,081 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | F Tax w/h | 2026-02-15 | 2026-02-18 | 325 | $243.45 | $79.1K | 114,288 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | M Exercise | 2026-02-15 | 2026-02-18 | 635 | — | $0 | 114,613 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | F Tax w/h | 2026-02-15 | 2026-02-18 | 310 | $243.45 | $75.5K | 113,978 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | M Exercise | 2026-02-15 | 2026-02-18 | 606 | — | $0 | 114,288 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise | 2026-02-15 | 2026-02-18 | 492 | — | $0 | 25,512 | SEC↗ |
| Swanson James D. | EVP, CIO | F Tax w/h | 2026-02-15 | 2026-02-18 | 214 | $243.45 | $52.1K | 25,298 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise | 2026-02-15 | 2026-02-18 | 709 | — | $0 | 26,007 | SEC↗ |
| Swanson James D. | EVP, CIO | F Tax w/h | 2026-02-15 | 2026-02-18 | 309 | $243.45 | $75.2K | 25,698 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise deriv | 2026-02-13 | 2026-02-18 | 8,594 | — | $0 | 0 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise deriv | 2026-02-13 | 2026-02-18 | 408 | — | $0 | 0 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise deriv | 2026-02-13 | 2026-02-18 | 73,054 | — | $0 | 0 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise deriv | 2026-02-13 | 2026-02-18 | 3,469 | — | $0 | 0 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise deriv | 2026-02-13 | 2026-02-18 | 4,378 | — | $0 | 0 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise deriv | 2026-02-13 | 2026-02-18 | 499 | — | $0 | 0 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise deriv | 2026-02-13 | 2026-02-18 | 1,302 | — | $0 | 0 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise deriv | 2026-02-13 | 2026-02-18 | 27,412 | — | $0 | 0 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise deriv | 2026-02-13 | 2026-02-18 | 651 | — | $0 | 0 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise deriv | 2026-02-13 | 2026-02-18 | 13,706 | — | $0 | 0 | SEC↗ |
| Decker Robert J | VP Corporate Controller | M Exercise deriv | 2026-02-13 | 2026-02-18 | 312 | — | $0 | 0 | SEC↗ |
| Decker Robert J | VP Corporate Controller | M Exercise deriv | 2026-02-13 | 2026-02-18 | 2,741 | — | $0 | 0 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise deriv | 2026-02-13 | 2026-02-18 | 37,463 | — | $0 | 0 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise deriv | 2026-02-13 | 2026-02-18 | 1,779 | — | $0 | 0 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | M Exercise deriv | 2026-02-13 | 2026-02-18 | 410 | — | $0 | 0 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | M Exercise deriv | 2026-02-13 | 2026-02-18 | 3,602 | — | $0 | 0 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | M Exercise deriv | 2026-02-13 | 2026-02-18 | 13,706 | — | $0 | 0 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | M Exercise deriv | 2026-02-13 | 2026-02-18 | 651 | — | $0 | 0 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise deriv | 2026-02-13 | 2026-02-18 | 447 | — | $0 | 0 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise deriv | 2026-02-13 | 2026-02-18 | 9,412 | — | $0 | 0 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise deriv | 2026-02-13 | 2026-02-18 | 19,368 | — | $0 | 0 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise deriv | 2026-02-13 | 2026-02-18 | 22,191 | — | $0 | 0 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | F Tax w/h | 2026-02-13 | 2026-02-18 | 3,748 | $244.55 | $916.6K | 28,704 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise | 2026-02-13 | 2026-02-18 | 8,594 | — | $0 | 32,452 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | F Tax w/h | 2026-02-13 | 2026-02-18 | 144 | $244.55 | $35.2K | 23,858 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | M Exercise | 2026-02-13 | 2026-02-18 | 408 | — | $0 | 24,002 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | F Tax w/h | 2026-02-13 | 2026-02-18 | 31,679 | $244.55 | $7.75M | 319,822 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise | 2026-02-13 | 2026-02-18 | 73,054 | — | $0 | 351,501 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | F Tax w/h | 2026-02-13 | 2026-02-18 | 989 | $244.55 | $241.9K | 278,447 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise | 2026-02-13 | 2026-02-18 | 3,469 | — | $0 | 279,436 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | F Tax w/h | 2026-02-13 | 2026-02-18 | 8 | $244.55 | $2.0K | 22,616 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 2026-02-13 | 2026-02-18 | 499 | — | $0 | 22,624 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 2026-02-13 | 2026-02-18 | 4,378 | — | $0 | 26,994 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | F Tax w/h | 2026-02-13 | 2026-02-18 | 1,816 | $244.55 | $444.1K | 25,178 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | F Tax w/h | 2026-02-13 | 2026-02-18 | 13,547 | $244.55 | $3.31M | 192,771 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | F Tax w/h | 2026-02-13 | 2026-02-18 | 409 | $244.55 | $100.0K | 178,906 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise | 2026-02-13 | 2026-02-18 | 27,412 | — | $0 | 206,318 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise | 2026-02-13 | 2026-02-18 | 1,302 | — | $0 | 179,315 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise | 2026-02-13 | 2026-02-18 | 13,706 | — | $0 | 29,591 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | F Tax w/h | 2026-02-13 | 2026-02-18 | 7,011 | $244.55 | $1.71M | 22,580 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | F Tax w/h | 2026-02-13 | 2026-02-18 | 314 | $244.55 | $76.8K | 15,885 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise | 2026-02-13 | 2026-02-18 | 651 | — | $0 | 16,199 | SEC↗ |
| Decker Robert J | VP Corporate Controller | F Tax w/h | 2026-02-13 | 2026-02-18 | 762 | $244.55 | $186.3K | 23,188 | SEC↗ |
| Decker Robert J | VP Corporate Controller | M Exercise | 2026-02-13 | 2026-02-18 | 2,741 | — | $0 | 23,950 | SEC↗ |
| Decker Robert J | VP Corporate Controller | F Tax w/h | 2026-02-13 | 2026-02-18 | 104 | $244.55 | $25.4K | 21,209 | SEC↗ |
| Decker Robert J | VP Corporate Controller | M Exercise | 2026-02-13 | 2026-02-18 | 312 | — | $0 | 21,313 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise | 2026-02-13 | 2026-02-18 | 37,463 | — | $0 | 51,463 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | F Tax w/h | 2026-02-13 | 2026-02-18 | 15,948 | $244.55 | $3.90M | 35,515 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | M Exercise | 2026-02-13 | 2026-02-18 | 1,779 | — | $0 | 37,294 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | F Tax w/h | 2026-02-13 | 2026-02-18 | 507 | $244.55 | $124.0K | 36,787 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | M Exercise | 2026-02-13 | 2026-02-18 | 410 | — | $0 | 16,819 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | F Tax w/h | 2026-02-13 | 2026-02-18 | 135 | $244.55 | $33.0K | 16,684 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | M Exercise | 2026-02-13 | 2026-02-18 | 3,602 | — | $0 | 20,286 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | F Tax w/h | 2026-02-13 | 2026-02-18 | 1,027 | $244.55 | $251.2K | 19,259 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | F Tax w/h | 2026-02-13 | 2026-02-18 | 6,414 | $244.55 | $1.57M | 113,682 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | M Exercise | 2026-02-13 | 2026-02-18 | 13,706 | — | $0 | 120,096 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | F Tax w/h | 2026-02-13 | 2026-02-18 | 217 | $244.55 | $53.1K | 106,390 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | M Exercise | 2026-02-13 | 2026-02-18 | 651 | — | $0 | 106,607 | SEC↗ |
| Swanson James D. | EVP, CIO | S Sale | 2026-02-13 | 2026-02-18 | 22,191 | $243.71 | $5.41M | 25,020 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise | 2026-02-13 | 2026-02-18 | 22,191 | $162.75 | $3.61M | 47,211 | SEC↗ |
| Swanson James D. | EVP, CIO | S Sale | 2026-02-13 | 2026-02-18 | 19,368 | $243.76 | $4.72M | 25,020 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise | 2026-02-13 | 2026-02-18 | 19,368 | $165.89 | $3.21M | 44,388 | SEC↗ |
| Swanson James D. | EVP, CIO | F Tax w/h | 2026-02-13 | 2026-02-18 | 3,547 | $244.55 | $867.4K | 25,020 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise | 2026-02-13 | 2026-02-18 | 447 | — | $0 | 19,298 | SEC↗ |
| Swanson James D. | EVP, CIO | M Exercise | 2026-02-13 | 2026-02-18 | 9,412 | — | $0 | 28,567 | SEC↗ |
| Swanson James D. | EVP, CIO | F Tax w/h | 2026-02-13 | 2026-02-18 | 143 | $244.55 | $35.0K | 19,155 | SEC↗ |
| Broadhurst Vanessa | EVP, Global Corp Affairs | A Award deriv | 2026-02-09 | 2026-02-11 | 8,594 | — | $0 | 8,594 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | A Award deriv | 2026-02-09 | 2026-02-11 | 13,706 | — | $0 | 13,706 | SEC↗ |
| Decker Robert J | VP Corporate Controller | A Award deriv | 2026-02-09 | 2026-02-11 | 2,741 | — | $0 | 2,741 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | A Award deriv | 2026-02-09 | 2026-02-11 | 73,054 | — | $0 | 73,054 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | A Award deriv | 2026-02-09 | 2026-02-11 | 13,706 | — | $0 | 13,706 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | A Award deriv | 2026-02-09 | 2026-02-11 | 3,602 | — | $0 | 3,602 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | A Award deriv | 2026-02-09 | 2026-02-11 | 4,378 | — | $0 | 4,378 | SEC↗ |
| Swanson James D. | EVP, CIO | A Award deriv | 2026-02-09 | 2026-02-11 | 9,412 | — | $0 | 9,412 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | A Award deriv | 2026-02-09 | 2026-02-11 | 27,412 | — | $0 | 27,412 | SEC↗ |
| Wolk Joseph J | Exec VP, CFO | A Award deriv | 2026-02-09 | 2026-02-11 | 37,463 | — | $0 | 37,463 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | M Exercise deriv | 2026-02-06 | 2026-02-09 | 38,945 | $101.87 | $3.97M | 0 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | M Exercise deriv | 2026-02-06 | 2026-02-09 | 5,625 | $101.87 | $573.0K | 0 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise deriv | 2026-02-06 | 2026-02-10 | 15,571 | $101.87 | $1.59M | 0 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | M Exercise | 2026-02-06 | 2026-02-09 | 38,945 | $101.87 | $3.97M | 133,226 | SEC↗ |
| Wengel Kathryn E | EVP, Chief TO and Risk Offic | F Tax w/h | 2026-02-06 | 2026-02-09 | 27,270 | $239.99 | $6.54M | 105,956 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | F Tax w/h | 2026-02-06 | 2026-02-09 | 3,335 | $239.99 | $800.4K | 16,409 | SEC↗ |
| Mulholland Kristen | EVP, Chief HR Officer | M Exercise | 2026-02-06 | 2026-02-09 | 5,625 | $101.87 | $573.0K | 19,744 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | F Tax w/h | 2026-02-06 | 2026-02-10 | 10,335 | $239.99 | $2.48M | 22,125 | SEC↗ |
| Schmid Timothy | EVP, WW Chair, MedTech | M Exercise | 2026-02-06 | 2026-02-10 | 15,571 | $101.87 | $1.59M | 32,460 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise deriv | 2026-02-05 | 2026-02-06 | 8,921 | $129.51 | $1.16M | 0 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | F Tax w/h | 2026-02-05 | 2026-02-06 | 6,226 | $237.90 | $1.48M | 15,548 | SEC↗ |
| Forminard Elizabeth | EVP, Chief Legal Officer | M Exercise | 2026-02-05 | 2026-02-06 | 8,921 | $129.51 | $1.16M | 21,774 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | S Sale | 2026-01-26 | 2026-01-28 | 51,218 | $220.99 | $11.32M | 79,634 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | S Sale | 2026-01-26 | 2026-01-28 | 48,782 | $221.48 | $10.80M | 30,852 | SEC↗ |
| Pinto Daniel E | Director | A Award deriv | 2025-12-09 | 2025-12-11 | 155 | $202.12 | $31.2K | 331 | SEC↗ |
| HEWSON MARILLYN A | Director | A Award deriv | 2025-12-09 | 2025-12-11 | 247 | $202.12 | $50.0K | 14,153 | SEC↗ |
| Woods Eugene A. | Director | A Award deriv | 2025-12-09 | 2025-12-11 | 186 | $202.12 | $37.5K | 5,058 | SEC↗ |
| MORIKIS JOHN G | Director | P Buy | 2025-11-26 | 2025-12-01 | 1,250 | $206.15 | $257.7K | 1,849 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | M Exercise deriv | 2025-10-17 | 2025-10-20 | 21,721 | $157.92 | $3.43M | 43,442 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | S Sale | 2025-10-17 | 2025-10-20 | 21,721 | $192.71 | $4.19M | 10,658 | SEC↗ |
| REED JOHN C | EVP, Innovative Medicine, R& | M Exercise | 2025-10-17 | 2025-10-20 | 21,721 | $157.92 | $3.43M | 32,379 | SEC↗ |
| Woods Eugene A. | Director | A Award deriv | 2025-09-09 | 2025-09-11 | 211 | $178.07 | $37.5K | 4,841 | SEC↗ |
| Pinto Daniel E | Director | A Award deriv | 2025-09-09 | 2025-09-11 | 175 | $178.07 | $31.2K | 175 | SEC↗ |
| HEWSON MARILLYN A | Director | A Award deriv | 2025-09-09 | 2025-09-11 | 281 | $178.07 | $50.0K | 13,817 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise deriv | 2025-09-04 | 2025-09-05 | 56,471 | $101.87 | $5.75M | 0 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | S Sale | 2025-09-04 | 2025-09-05 | 56,471 | $177.81 | $10.04M | 178,013 | SEC↗ |
| Taubert Jennifer L | EVP, WWC. Innovative Medicin | M Exercise | 2025-09-04 | 2025-09-05 | 56,471 | $101.87 | $5.75M | 234,484 | SEC↗ |
| Forminard Elizabeth | Executive VP, General Counse | M Exercise deriv | 2025-08-29 | 2025-09-03 | 11,521 | $115.67 | $1.33M | 0 | SEC↗ |
| Forminard Elizabeth | Executive VP, General Counse | M Exercise | 2025-08-29 | 2025-09-03 | 11,521 | $115.67 | $1.33M | 22,423 | SEC↗ |
| Forminard Elizabeth | Executive VP, General Counse | F Tax w/h | 2025-08-29 | 2025-09-03 | 9,570 | $177.20 | $1.70M | 12,853 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise deriv | 2025-08-22 | 2025-08-25 | 125,824 | $101.87 | $12.82M | 0 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | S Sale | 2025-08-22 | 2025-08-25 | 125,824 | $179.21 | $22.55M | 275,967 | SEC↗ |
| Duato Joaquin | CEO and Chairman of the Boar | M Exercise | 2025-08-22 | 2025-08-25 | 125,824 | $101.87 | $12.82M | 401,791 | SEC↗ |